Back to Results
First PageMeta Content
Benzoates / Carbamates / Prodrugs / Abiraterone / Antiandrogens / Pyridines / Prostate cancer / Docetaxel / Mitoxantrone / Chemistry / Medicine / Organic chemistry


PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application
Add to Reading List

Document Date: 2014-11-10 21:39:36

Open Document

File Size: 511,21 KB

Share Result on Facebook

City

Trial / Milan / /

Company

Medical Oncology Group of Australia / B9182 / Janssen-Cilag Pty Ltd / The New England Journal / /

Country

Italy / Australia / /

Currency

USD / /

Event

FDA Phase / /

IndustryTerm

cancer therapy / leukemia / treatment of a patient with metastatic advanced prostate cancer / treatment of metastatic advanced prostate cancer / therapy for patients with metastatic prostate cancer / /

MedicalCondition

cancers / leukemia / Proposed Therapy Prostate cancer / metastatic prostate cancer / common cancer / symptomatic hormone-resistant prostate cancer / cancer / disease / metastatic advanced prostate cancer / progressive disease / tumour / carcinoma / asymptomatic hormone-refractory carcinoma / metastatic castration-resistant prostate cancer / pain / refractory prostate cancer / symptomatic hormoneresistant prostate cancer / symptomatic hormonerefractory prostate cancer / prostate cancer / resistant prostate cancer / hormone-refractory prostate cancer / /

MedicalTreatment

retreatment / alternative therapies / chemotherapy / radiotherapy / hormone therapy / chemotherapies / hormonal therapies / cancer therapy / /

Organization

World Health Organization / American Society of Clinical Oncology / American Society for Clinical Oncology / /

Position

Evaluator / nurse / First author / /

Product

carboplatin / Abiraterone / prednisolone / cyclophosphamide / prednisone / Hydrocortisone / mitoxantrone / mitoxantrone/low / AA-301 / /

PublishedMedium

The New England Journal of Medicine / Journal of Clinical Oncology / /

Technology

author Abiraterone COU-AA-301 de Bono JS et al Protocol / chemotherapy / treating cancer / /

SocialTag